Monday, August 31, 2020

Focusing on New Developments of COVID-19 Vaccines, Pharma Sources Insight (August 2020) is Launched!

View this e-mail online
Pharma Sources Insight
August 2020

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

Your FREE source of news and insights into China pharmaceutical industry and more!

Start Reading
 
Pharma Sources Insight August 2020 focuses on the following topics:
COVID-19
-Developments of COVID-19 Diagnostic Test
-Will the Bottles be Enough with the Marketing of COVID-19 Vaccine?
-Designing the Messenger: Story of the mRNA Vaccine
-Inactivated Virus Vaccines vs. mRNA Vaccines: Differences Between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines
Global News
-With Up to 18 First Generics, Hansoh Ranking Second in the Industry in China
-A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years
-The Layout of Inhalation Formulations in the Chinese Market (I)
-The Layout of Inhalation Formulations in the Chinese Market (II)
Brand Story
-Oriented by Product Innovation, Dongtai Pharma Striving to Build a Global Characteristic Pharmaceutical Brand
-Interview Changzhou Golden Bright Pharmaceutical Factory: How to achieve safe production while ensuring quality?
Industry Insight
- Advantages to Using CROs
 
Why Join PharmaSources.com?

PharmaSources.com, as a vertical e-commerce online marketplace serving the pharmaceutical industry, is now upgraded from CPhI.CN (www.en-cphi.cn) after its 10 years' developing in the industry.

Now it delivers services to over 232,000 active members across 211 countries and regions, featuring over 1,600,000 products in 30 major categories spanning the entire pharma supply chain.

Our mission is to connect buyers with suppliers of the global pharmaceutical industry.

Maximized Exposure One-Stop-Shop of Pharma Supply Chain
Company Video and 1,000 products can be released on the online store through both PC and mobile terminals. Covering 14 niche markets including APIs, Pharma Excipients, Packaging, Lab, Natural Extracts, etc.
One-Click-Quote Easy Matchmaking
Intelligent matching system helps you find trustworthy suppliers. Have a video meeting online with appointed partner at CPhI & P-MEC China 2020.
 
Article Contribution:Julia Zhang
Tel:+86-21-33392274 E-Mail:julia.zhang@imsinoexpo.com
If you do not want to receive Email from us, please click here.

Thursday, August 27, 2020

Highlights from China's Pharma & Healthcare Industry

2019 saw the 10-year anniversary of China's medical reform under which the country's health sector has seen a new era of progress.
CPhI & P-MEC China
Highlights from China's Pharma & Healthcare Industry
After 10-year medical reform in China,  the country's health sector has seen a new era of progress, highlighted by restructured government framework and tangible outcomes such as universal health coverage, hospital reform and medical insurance payment to the drug supply system.
Under the Belt and Road Initiative, overseas investment grew rapidly along with M&A and in and out-licensing, whilst the healthcare reform continued to unleash new market opportunities. 
The accelerated clinical trial authorization, expedited review and approval procedures, expanded volume-based procurement, and innovative breakthrough designation, etc. are all encouraged due to regulatory reforms in China. 
Want to Learn More? 
If you'd like to learn more about China's healthcare industry, join us at CPhI & P-MEC China 2020 this December in Shanghai. There you'll have the chance to meet Chinese pharma experts and industry insiders who can share their first-hand knowledge, while learning from a comprehensive educational programme. 
CPhI & P-MEC China Zones
CPhI & P-MEC China 2020, with the co-located shows FDF, bioLIVE, NEX, InnoPack and LABWORLD China, are expected to cover a total area of 210,000+ sqm, and draw 75,000+ visits of  professionals from the global pharmaceutical industry.

Pre-register now for free to join us and celebrate the 20th anniversary of CPhI China at SNIEC, Shanghai during 16-18 December 2020! 
CPhI & P-MEC China 2020
16-18 December 2020 | SNIEC, Shanghai, China

Monday, August 24, 2020

Now Live! - CPhI China Top API Exporters & Products

CPhI & P-MEC China E-Trade Season
Now Live! - CPhI China Top API Exporters & Products
@CPhI & P-MEC China E-Trade Season

Powered by CPhI China and its B2B portal Pharmasources.com, the E-Trade Session CPhI China Top API Exporters & Products is launched today! Join now for free and get connected with China's top 100 API exporters!
What's in it for you?

      1         Authorized shortlist of top exporters to source from directly

      2         Easy access and One-Click inquiry-making at suppliers’ online showrooms

      3         Free online match and meet service to e-meet quality suppliers

      4         Key insights and statistics of industry for free download
Source the Most Popular APIs from China

 
Idebenone 
Azelnidipine
L-TRYPTOPHAN
(±)-2-Amino-1-butanol
Medetomidine Hydrochloride
L-Alanine
Top API Exporters Shortlisted for Your Need
Based on Yearly Export Value 
Jiangxi Tianxin Pharmaceutical Co.,Ltd.
Zhejiang Chiral Medicine Chemicals Co.,Ltd
 
Zhejiang Xianju Pharmaceutical Co.,Ltd.
Shanghai Medicines & Health Products Import & Export Co., Ltd.
Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
Changzhou Qianhong Bio-pharma Co., Ltd.
 
Guobang Pharma Ltd.
 
Zhejiang Hengdian Apeloa Imp. &Exp. Co., Ltd.
Contact Us
Yingqi Shi   Yingqi.Shi@imsinoexpo.com   +86-21-33392421